Iron Injection Safety and Effectiveness Study in Healthy Adults
Treatments studied
This study tests a new iron injection medication in healthy people to ensure it works the same way as a reference version. Participants will receive the injection while fasting and undergo blood tests to measure how the body processes the iron.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy adult aged 18–55 years
- Weigh at least 50 kg and have a normal body mass index (BMI between 19–26)
- Have no serious allergies to iron, medications, or severe asthma or eczema
- Have no history of iron overload diseases, hemolytic anemia, or recent anemia requiring transfusion
- Agree to use effective contraception for 3 months after the last injection and not donate blood or sperm/eggs during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an iron injection for treating iron deficiency anemia. It checks how the medicine works in the body, and may help people whose blood iron is too low.
This study tests a new iron medicine (Ferric Bepectate) against an existing one (Ferric Carboxymaltose) to see if it works just as well for people with iron deficiency anemia. It aims to help patients with low iron and low hemoglobin get effective treatment.
This study tests whether giving iron through a vein can improve quality of life in older adults who recently had a heart attack or unstable angina and also have low iron levels. If you qualify, you would receive either iron or a placebo (inactive substance) to see if iron helps you feel better and recover faster.
This trial tests whether giving an intravenous iron supplement (ferric derisomaltose) can help prevent anemia and improve quality of life in obese patients who have low iron stores. It aims to see if this treatment can boost energy and reduce fatigue.
This study checks how common iron deficiency is in people with HFpEF (heart failure with preserved pumping strength) and tests whether an iron infusion (Ferinject®) improves health. It targets people with stable heart symptoms and lab results showing low iron stores or related iron deficiency.
This trial compares two types of iron supplements (Sucrosomial Iron and Ferric Maltol) to see which works better and causes fewer side effects in women with low iron levels. It may help if you have mild to moderate anemia and are not taking other iron supplements.
Hear when a new Healthy Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.